High Expression of HERV-K (HML-2) Might Stimulate Interferon in COVID-19 Patients
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High Expression of HERV-K (HML-2) Might Stimulate Interferon in COVID-19 Patients
Authors
Keywords
-
Journal
Viruses-Basel
Volume 14, Issue 5, Pages 996
Publisher
MDPI AG
Online
2022-05-09
DOI
10.3390/v14050996
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HERV-K Gag RNA and Protein Levels Are Elevated in Malignant Regions of the Prostate in Males with Prostate Cancer
- (2021) Simin D. Rezaei et al. Viruses-Basel
- Bioreactor production of rVSV‐based vectors in Vero cell suspension cultures
- (2021) Sascha Kiesslich et al. BIOTECHNOLOGY AND BIOENGINEERING
- IFN-γ and TNF-α drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue inflammation
- (2021) Fan Zhang et al. Genome Medicine
- Infection by Diverse HIV-1 Subtypes Leads to Different Elevations in HERV-K Transcriptional Levels in Human T Cell Lines
- (2021) Xi Li et al. Frontiers in Microbiology
- Endogenous retroviruses promote homeostatic and inflammatory responses to the microbiota
- (2021) Djalma S. Lima-Junior et al. CELL
- Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19
- (2021) Benjamin Krämer et al. IMMUNITY
- Human endogenous retrovirus K (HERV-K) env in neuronal extracellular vesicles: a new biomarker of motor neuron disease
- (2021) Yuan Li et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Different Profiles of Antibodies and Cytokines Were Found Between Severe and Moderate COVID-19 Patients
- (2021) Yaolin Guo et al. Frontiers in Immunology
- Age-Related Expression of IFN-λ1 Versus IFN-I and Beta-Defensins in the Nasopharynx of SARS-CoV-2-Infected Individuals
- (2021) Charly Gilbert et al. Frontiers in Immunology
- Process Development for Newcastle Disease Virus-Vectored Vaccines in Serum-Free Vero Cell Suspension Cultures
- (2021) Julia Puppin Chaves Fulber et al. Vaccines
- Upregulation of Human Endogenous Retroviruses in Bronchoalveolar Lavage Fluid of COVID-19 Patients
- (2021) Konstantina Kitsou et al. Microbiology Spectrum
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
- (2020) Jasper Fuk-Woo Chan et al. LANCET
- A distinct name is needed for the new coronavirus
- (2020) Shibo Jiang et al. LANCET
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- Interferon, restriction factors and SUMO pathways
- (2020) Faten El-Asmi et al. CYTOKINE & GROWTH FACTOR REVIEWS
- COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons
- (2020) Shivraj Hariram Nile et al. CYTOKINE & GROWTH FACTOR REVIEWS
- COVID ‐19: lambda interferon against viral load and hyperinflammation
- (2020) Evangelos Andreakos et al. EMBO Molecular Medicine
- Type I IFN immunoprofiling in COVID-19 patients
- (2020) Sophie Trouillet-Assant et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Identification of the distribution of human endogenous retroviruses K (HML-2) by PCR-based target enrichment sequencing
- (2020) Bei Xue et al. Retrovirology
- Efficacy and safety of interferon β-1a in treatment of severe COVID-19: A randomized clinical trial
- (2020) Effat Davoudi-Monfared et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antiviral activities of type I interferons to SARS-CoV-2 infection
- (2020) Emily Mantlo et al. ANTIVIRAL RESEARCH
- Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures
- (2020) Abigail Vanderheiden et al. JOURNAL OF VIROLOGY
- Human Endogenous Retrovirus K (HML-2) in Health and Disease
- (2020) Bei Xue et al. Frontiers in Microbiology
- Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2
- (2020) Idoia Busnadiego et al. mBio
- Evasion of Type I Interferon by SARS-CoV-2
- (2020) Hongjie Xia et al. Cell Reports
- Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes
- (2020) Rajendra Karki et al. CELL
- COVID-19-neutralizing antibodies predict disease severity and survival
- (2020) Wilfredo F. Garcia-Beltran et al. CELL
- IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes
- (2019) Rudragouda Channappanavar et al. JOURNAL OF CLINICAL INVESTIGATION
- Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke
- (2018) David Sacks et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Human endogenous retrovirus-K (HML-2): a comprehensive review
- (2018) Marta Garcia-Montojo et al. CRITICAL REVIEWS IN MICROBIOLOGY
- Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss
- (2018) Huayang Liu et al. NATURE MEDICINE
- Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness
- (2017) Ioanna E. Galani et al. IMMUNITY
- HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features
- (2017) Ayele Argaw-Denboba et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit
- (2017) Jing Wang et al. NUCLEIC ACIDS RESEARCH
- Identification of Interferon-Stimulated Gene Proteins That Inhibit Human Parainfluenza Virus Type 3
- (2016) M. A. G. Rabbani et al. JOURNAL OF VIROLOGY
- Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset
- (2015) Jasper Fuk-Woo Chan et al. JOURNAL OF INFECTIOUS DISEASES
- Intrinsic retroviral reactivation in human preimplantation embryos and pluripotent cells
- (2015) Edward J. Grow et al. NATURE
- The HERV-K Human Endogenous Retrovirus Envelope Protein Antagonizes Tetherin Antiviral Activity
- (2014) C. Lemaitre et al. JOURNAL OF VIROLOGY
- Attenuation and Restoration of Severe Acute Respiratory Syndrome Coronavirus Mutant Lacking 2'-O-Methyltransferase Activity
- (2014) V. D. Menachery et al. JOURNAL OF VIROLOGY
- Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission
- (2013) Benoit Guery et al. LANCET
- Detection of Human Endogenous Retrovirus K (HERV-K) Transcripts in Human Prostate Cancer Cell Lines
- (2013) Lorenzo Agoni et al. Frontiers in Oncology
- Expression of Human Endogenous Retrovirus Type K (HML-2) Is Activated by the Tat Protein of HIV-1
- (2012) M. J. Gonzalez-Hernandez et al. JOURNAL OF VIROLOGY
- ISG56 and IFITM1 Proteins Inhibit Hepatitis C Virus Replication
- (2011) A. Raychoudhuri et al. JOURNAL OF VIROLOGY
- IFIT1 is an antiviral protein that recognizes 5′-triphosphate RNA
- (2011) Andreas Pichlmair et al. NATURE IMMUNOLOGY
- Endogenous retroviral pathogenesis in lupus
- (2010) Andras Perl et al. CURRENT OPINION IN RHEUMATOLOGY
- Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines
- (2009) P Noel Barrett et al. Expert Review of Vaccines
- Severe Acute Respiratory Syndrome Coronavirus M Protein Inhibits Type I Interferon Production by Impeding the Formation of TRAF3·TANK·TBK1/IKKϵ Complex
- (2009) Kam-Leung Siu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase
- (2009) Y. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ISG56 is a negative-feedback regulator of virus-triggered signaling and cellular antiviral response
- (2009) Y. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More